Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP ...

Here are three of the biggest mistakes that doctors say people make while taking Ozempic and similar medications. 🩺 SIGN UP ...

Ozempic can induce some rather unpleasant side effects, from feeling sick and bloated, to dizziness and even diarrhea.

My dad, Michael Mosley, was an inspiration to millions of people worldwide – particularly those living with obesity or type 2 ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...